Host CD39 Deficiency Affects Radiation-Induced Tumor Growth Delay and Aggravates Radiation-Induced Normal Tissue Toxicity.

ATP CD73 cancer ionizing radiation purinergic signaling

Journal

Frontiers in oncology
ISSN: 2234-943X
Titre abrégé: Front Oncol
Pays: Switzerland
ID NLM: 101568867

Informations de publication

Date de publication:
2020
Historique:
received: 23 04 2020
accepted: 10 09 2020
entrez: 16 11 2020
pubmed: 17 11 2020
medline: 17 11 2020
Statut: epublish

Résumé

The ectonucleoside triphosphate diphosphohydrolase (CD39)/5' ectonuclotidase (CD73)-dependent purinergic pathway emerges as promising cancer target. Yet, except for own previous work revealing a pathogenic role of CD73 and adenosine in radiation-induced lung fibrosis, the role of purinergic signaling for radiotherapy outcome remained elusive. Here we used C57BL/6 wild-type (WT), CD39 knockout (CD39

Identifiants

pubmed: 33194619
doi: 10.3389/fonc.2020.554883
pmc: PMC7649817
doi:

Types de publication

Journal Article

Langues

eng

Pagination

554883

Informations de copyright

Copyright © 2020 Meyer, Klein, de Leve, Szymonowicz, Stuschke, Robson, Jendrossek and Wirsdörfer.

Références

Front Immunol. 2014 Jul 10;5:304
pubmed: 25071765
Proc Natl Acad Sci U S A. 2010 Jan 26;107(4):1547-52
pubmed: 20080644
Nat Rev Cancer. 2017 Dec;17(12):709-724
pubmed: 29059149
Am J Respir Cell Mol Biol. 1991 Aug;5(2):155-62
pubmed: 1892646
Cancer Discov. 2014 Aug;4(8):879-88
pubmed: 25035124
J Dent Res. 2008 Jun;87(6):564-8
pubmed: 18502966
Nat Med. 1999 Sep;5(9):1010-7
pubmed: 10470077
Am J Respir Crit Care Med. 2010 Sep 15;182(6):774-83
pubmed: 20522787
PLoS One. 2013 Oct 03;8(10):e76731
pubmed: 24098558
Immunol Lett. 2019 Jan;205:51-58
pubmed: 29958894
Oncogene. 2017 Jan 19;36(3):293-303
pubmed: 27321181
Oncogene. 2015 Apr 2;34(14):1831-42
pubmed: 24837364
Br J Pharmacol. 2003 Nov;140(6):1009-18
pubmed: 14530217
Lancet Oncol. 2009 Jul;10(7):718-26
pubmed: 19573801
N Engl J Med. 2017 Nov 16;377(20):1919-1929
pubmed: 28885881
Arterioscler Thromb Vasc Biol. 2012 Apr;32(4):865-9
pubmed: 22423038
Front Oncol. 2018 Mar 12;8:56
pubmed: 29594038
PLoS One. 2012;7(7):e40829
pubmed: 22792409
Cancer Immunol Res. 2020 Apr;8(4):465-478
pubmed: 32047024
Clin Cancer Res. 2009 Oct 15;15(20):6348-57
pubmed: 19825957
J Clin Pathol. 1988 Apr;41(4):467-70
pubmed: 3366935
J Exp Med. 2010 Nov 22;207(12):2561-8
pubmed: 20975043
J Exp Med. 2007 Jun 11;204(6):1257-65
pubmed: 17502665
Eur J Pharmacol. 2007 Dec 22;577(1-3):35-43
pubmed: 17878054
Cancer Immunol Res. 2015 Mar;3(3):254-65
pubmed: 25403716
Carcinogenesis. 2018 Feb 9;39(2):242-251
pubmed: 29228209
Purinergic Signal. 2012 Sep;8(3):437-502
pubmed: 22555564
Radiat Res. 2016 Aug;186(2):153-61
pubmed: 27387862
J Leukoc Biol. 2001 Apr;69(4):605-12
pubmed: 11310847
Cell Physiol Biochem. 2012;30(3):666-77
pubmed: 22854535
Curr Opin Pharmacol. 2016 Aug;29:7-16
pubmed: 27209048
Neoplasma. 2016;63(2):201-7
pubmed: 26774140
J Immunother Cancer. 2020 Feb;8(1):
pubmed: 32098829
Immunol Rev. 2017 Nov;280(1):83-92
pubmed: 29027229
Front Immunol. 2017 Mar 13;8:229
pubmed: 28348554
Nano Lett. 2015 Nov 11;15(11):7488-96
pubmed: 26418302
Front Immunol. 2019 Oct 04;10:2301
pubmed: 31636635
PLoS One. 2012;7(12):e51164
pubmed: 23284663
Cancer Discov. 2014 Mar;4(3):280-91
pubmed: 24550033
Br J Radiol. 2018 Sep;91(1089):20170762
pubmed: 29630386
Oncotarget. 2018 Aug 07;9(61):31797-31811
pubmed: 30159123
J Immunother Cancer. 2018 Jun 18;6(1):57
pubmed: 29914571
Oncogene. 2014 Mar 6;33(10):1229-38
pubmed: 23503466
Immunol Lett. 2019 Jan;205:25-30
pubmed: 29550257
Cells. 2019 Dec 24;9(1):
pubmed: 31878283
Oncoimmunology. 2013 Sep 1;2(9):e26246
pubmed: 24319640
Am J Physiol Heart Circ Physiol. 2016 Jul 1;311(1):H286-98
pubmed: 27208163
Radiat Res. 2014 Aug;182(2):149-62
pubmed: 25036982
Immunobiology. 2015 Nov;220(11):1284-91
pubmed: 26224246
Radiat Oncol. 2017 Aug 24;12(1):142
pubmed: 28836991
Sci Rep. 2017 Sep 6;7(1):10636
pubmed: 28878242
J Immunol. 2011 Jul 15;187(2):676-83
pubmed: 21677139
J Immunother. 2013 Nov-Dec;36(9):477-89
pubmed: 24145359
Front Oncol. 2017 Sep 21;7:205
pubmed: 28983464
J Immunol. 2014 Dec 15;193(12):5904-13
pubmed: 25392527
J Natl Cancer Inst. 2011 Oct 5;103(19):1452-60
pubmed: 21903745
Eur J Cardiothorac Surg. 2014 Dec;46(6):e103-12
pubmed: 25312525
FASEB J. 2016 Jan;30(1):3-12
pubmed: 26333425
Proc Natl Acad Sci U S A. 2000 Mar 14;97(6):2840-5
pubmed: 10706632
Purinergic Signal. 2007 Mar;3(1-2):71-81
pubmed: 18404420
Oncol Rep. 2007 Jun;17(6):1341-6
pubmed: 17487388
Nat Methods. 2012 Jun 28;9(7):676-82
pubmed: 22743772
Front Immunol. 2019 Sep 04;10:2093
pubmed: 31552039
JCI Insight. 2017 Aug 17;2(16):
pubmed: 28814671
Antioxid Redox Signal. 2017 Apr 10;26(11):563-582
pubmed: 27572073
Cell Death Dis. 2014 Nov 27;5:e1539
pubmed: 25429616
Neoplasia. 2011 Mar;13(3):206-16
pubmed: 21390184
Cancer Lett. 2010 Apr 28;290(2):211-5
pubmed: 19822392
Am J Physiol Cell Physiol. 2016 Jan 15;310(2):C99-114
pubmed: 26491047
Cancer Cell. 2016 Sep 12;30(3):391-403
pubmed: 27622332
Radiat Oncol. 2015 Feb 20;10:45
pubmed: 25889053
J Clin Invest. 2011 Jun;121(6):2371-82
pubmed: 21537079
Biomed Pharmacother. 2015 Apr;71:79-83
pubmed: 25960219
Trans Am Clin Climatol Assoc. 2018;129:132-139
pubmed: 30166707
Clin Cancer Res. 2003 Jun;9(6):1957-71
pubmed: 12796357
Am J Physiol Lung Cell Mol Physiol. 2015 May 15;308(10):L1046-57
pubmed: 25820525
Int J Radiat Biol. 1999 May;75(5):629-38
pubmed: 10374945
Immunol Lett. 2019 Jan;205:31-39
pubmed: 29758241
Nat Rev Cancer. 2013 Dec;13(12):842-57
pubmed: 24226193
J Exp Med. 2004 Dec 6;200(11):1395-405
pubmed: 15583013
Respir Res. 2018 May 28;19(1):103
pubmed: 29807526
J Cell Physiol. 2011 Sep;226(9):2438-47
pubmed: 21660967
Strahlenther Onkol. 2016 May;192(5):279-87
pubmed: 26961686
Cancer Res. 2016 May 15;76(10):3045-56
pubmed: 26921334
J Cell Physiol. 1992 Dec;153(3):539-49
pubmed: 1447315
Cells. 2019 Dec 20;9(1):
pubmed: 31861847
Oncoimmunology. 2018 Nov 2;8(1):e1523097
pubmed: 30546963
Lab Invest. 2020 Jul 1;:
pubmed: 32612286
Semin Radiat Oncol. 2019 Jan;29(1):6-15
pubmed: 30573185
Front Genet. 2016 Aug 09;7:147
pubmed: 27555866
Br J Cancer. 2009 May 5;100(9):1465-70
pubmed: 19367276
Tissue Cell. 2018 Aug;53:87-92
pubmed: 30060832
J Cell Biol. 1991 Jan;112(2):279-88
pubmed: 1988462
Ann Oncol. 2018 Feb 1;29(2):301-310
pubmed: 29309540
FASEB J. 2017 Jul;31(7):2869-2880
pubmed: 28325757
J Immunol. 2012 Jul 15;189(2):558-66
pubmed: 22685313
Am J Pathol. 2002 Jun;160(6):2231-44
pubmed: 12057925
J Neurochem. 1999 Feb;72(2):826-34
pubmed: 9930759
PLoS Comput Biol. 2020 Feb 5;16(2):e1007313
pubmed: 32023239
Biochim Biophys Acta. 2011 May;1808(5):1400-12
pubmed: 20888788
JACC Basic Transl Sci. 2018 Aug 28;3(4):563-572
pubmed: 30175280
Lancet Oncol. 2017 Jul;18(7):895-903
pubmed: 28551359
Front Oncol. 2018 Sep 10;8:367
pubmed: 30250827
Cancer Res. 2011 Apr 15;71(8):2892-900
pubmed: 21292811
Mol Cancer Res. 2016 Nov;14(11):1087-1096
pubmed: 27578770
Oncogenesis. 2015 May 18;4:e148
pubmed: 25985209
Sci Rep. 2017 Aug 2;7(1):7143
pubmed: 28769058
Mol Biol Cell. 2014 Oct 1;25(19):2905-18
pubmed: 25103241
Cold Spring Harb Protoc. 2016 Apr 01;2016(4):pdb.prot087379
pubmed: 27037069
QJM. 2014 Jul;107(7):515-9
pubmed: 24453283
Trends Immunol. 2009 Mar;30(3):102-8
pubmed: 19201652
Cancer Res. 2002 Mar 1;62(5):1462-70
pubmed: 11888921
Arch Biochem Biophys. 2013 May;533(1-2):47-54
pubmed: 23454010
Cancer Radiother. 2018 Oct;22(6-7):564-566
pubmed: 30170788
Radiat Oncol. 2014 Apr 25;9:98
pubmed: 24766907
Cell Physiol Biochem. 2012;29(5-6):687-96
pubmed: 22613969
Nucleosides Nucleotides Nucleic Acids. 2008 Jun;27(6):755-60
pubmed: 18600537
Antioxid Redox Signal. 2016 Jan 10;24(2):53-69
pubmed: 26066676
J Immunol. 2013 Jun 1;190(11):5874-81
pubmed: 23630355
Curr Opin Oncol. 2015 Jan;27(1):71-7
pubmed: 25402978
Cancer Res. 2018 Jan 1;78(1):115-128
pubmed: 29066514
PLoS Med. 2005 Sep;2(9):e251
pubmed: 16128620
Leuk Res. 2007 Nov;31(11):1575-8
pubmed: 17485110
Sci Rep. 2017 Jan 23;7:41138
pubmed: 28112237
Lancet Oncol. 2015 Feb;16(2):187-99
pubmed: 25601342
Oncoimmunology. 2019 Feb 19;8(5):e1574198
pubmed: 31069133
Oncoimmunology. 2017 Apr 21;6(6):e1320011
pubmed: 28680754
Antioxid Redox Signal. 2019 Jan 10;30(2):213-231
pubmed: 29463096
Cancer Lett. 2012 Aug 1;321(1):65-72
pubmed: 22388174
Int J Mol Sci. 2019 Mar 22;20(6):
pubmed: 30909368
Immunol Rev. 2017 Mar;276(1):121-144
pubmed: 28258700
Hepatology. 2008 Mar;47(3):1018-31
pubmed: 18302287
Oncotarget. 2017 Jan 31;8(5):8738-8751
pubmed: 28060732

Auteurs

Alina V Meyer (AV)

Medical School, Institute of Cell Biology (Cancer Research), University of Duisburg-Essen, Essen, Germany.

Diana Klein (D)

Medical School, Institute of Cell Biology (Cancer Research), University of Duisburg-Essen, Essen, Germany.

Simone de Leve (S)

Medical School, Institute of Cell Biology (Cancer Research), University of Duisburg-Essen, Essen, Germany.

Klaudia Szymonowicz (K)

Medical School, Institute of Cell Biology (Cancer Research), University of Duisburg-Essen, Essen, Germany.

Martin Stuschke (M)

Department of Radiotherapy, University Hospital Essen, Essen, Germany.

Simon C Robson (SC)

Departments of Medicine and Anesthesia, Beth Israel Deaconess Medical Center, Harvard Medical School, Harvard University, Boston, MA, United States.

Verena Jendrossek (V)

Medical School, Institute of Cell Biology (Cancer Research), University of Duisburg-Essen, Essen, Germany.

Florian Wirsdörfer (F)

Medical School, Institute of Cell Biology (Cancer Research), University of Duisburg-Essen, Essen, Germany.

Classifications MeSH